Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

The Vanderbilt University divulges new muscarinic M5 receptor antagonists

Jan. 10, 2022

Dana-Farber Cancer Institute patents UCP1 activators

Jan. 10, 2022

Wigen Biomedicine Technology synthesizes new Wee1 inhibitors

Jan. 7, 2022

Chinese researchers describe new GLP-1 receptor agonists

Jan. 7, 2022

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Jan. 7, 2022

Janssen Pharmaceutica discloses Mcl-1 inhibitors

Jan. 7, 2022

French researchers patent new antibacterial compounds

Jan. 7, 2022

Merck & Co. synthesizes RIPK1 inhibitors

Jan. 5, 2022

Vertex Pharmaceuticals identifies new APOL1 inhibitors

Jan. 5, 2022

Novartis presents new Cav1.2 activators

Jan. 5, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...